The unified social credit code/registration number of Jiangsu Chengxin Pharmaceutical Co., Ltd. is 91320681560294852Y, and the enterprise is in the opening state.
The business scope of Jiangsu Chengxin Pharmaceutical Co., Ltd. is: the production and sales of raw materials such as propionyl glutamine, oxiracetam, atorvastatin calcium, praziquantel, rosuvastatin calcium and telbivudine; Production and sales of ketoreductase; Production and sales of vitamin C glucoside; Sales of amino acid series products; Research, development, sales and technology transfer of chemical raw material intermediates and biomedical products (except for dangerous chemicals, drugs and other products stipulated by the state); Self-management and agency generally operate the import and export business of project goods and technologies. (Projects subject to approval according to law can only be operated after approval by relevant departments). In Jiangsu Province, the total registered capital of companies with similar business scope is1204.32 million yuan, and the main capital is concentrated in 44 enterprises with a scale of1000-50 million and over 50 million. In the province, the registered capital of enterprises is excellent.
Jiangsu Chengxin Pharmaceutical Co., Ltd. invested in 1 company and owned 1 branch company.
See more information and materials of Jiangsu Chengxin Pharmaceutical Co., Ltd. through Baidu Enterprise Credit.